Market Cap (In USD)
8.38 Million
Revenue (In USD)
968.7 Thousand
Net Income (In USD)
-10.95 Million
Avg. Volume
21.58 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.29-1.5
- PE
- -
- EPS
- -
- Beta Value
- 2.474
- ISIN
- US7168174081
- CUSIP
- 716817408
- CIK
- 1512922
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. John Lai
- Employee Count
- -
- Website
- https://www.petvivo.com
- Ipo Date
- 2014-09-08
- Details
- PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
More Stocks
-
NTDTYNTT DATA Corporation
NTDTY
-
LIOPYLion Corporation
LIOPY
-
181710NHN Corporation
181710
-
6744
-
3817SRA Holdings, Inc.
3817
-
AMO
-
5697Sanyu Co., Ltd.
5697
-
MCP